FHIT and breast carcinoma: FHIT expression is reduced in many breast cancers, and its nuclear translocation promotes breast cancer cell proliferation (Bianchi et al., 2015); moreover, loss of FHIT expression or function were correlated with patient poor prognosis and advanced stage (Campiglio et al., 1999; Arun et al., 2005).